Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gastl

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Methods in Molecular Medicine|February 23, 2011
Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerG Gastl, M Plante
Deutsche Medizinische Wochenschrift (1946)|September 30, 2004
[Target-oriented tumor therapy -- proof of the principle]G Gastl, W Hiddemann
Onkologie|April 11, 2013
Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. PrefaceG Gastl, C Dittrich
British Journal of Cancer|September 16, 1999
Platelets and VEGF blood levels in cancer patientsE Gunsilius, G Gastl
Blut|May 1, 1988
The biology of interferon actionsG Gastl, C Huber
European Journal of Immunology|November 1, 1982
Large granular lymphocytes: morphological studiesD Huhn, C Huber, G Gastl
Deutsche Medizinische Wochenschrift (1946)|September 30, 2004
[Complete remission of an idiopathic hypereosinophilic syndrome while using imatinib]D Wolf, G Gastl, H Rumpold
Oncology|January 1, 1985
Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trialC Huber, R Flener, G Gastl
Current Cancer Drug Targets|November 11, 2010
Current treatment concepts of Philadelphia-negative MPND Wolf, J Rudzki, G Gastl
Wiener Klinische Wochenschrift|January 6, 1984
[Löffler's parietal fibroplastic endocarditis--a case report]G Schnapka, G Gastl, F Hofstädter
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Methods in Molecular Medicine|February 23, 2011
Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerG Gastl, M Plante
Deutsche Medizinische Wochenschrift (1946)|September 30, 2004
[Target-oriented tumor therapy -- proof of the principle]G Gastl, W Hiddemann
Onkologie|April 11, 2013
Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. PrefaceG Gastl, C Dittrich
British Journal of Cancer|September 16, 1999
Platelets and VEGF blood levels in cancer patientsE Gunsilius, G Gastl
Blut|May 1, 1988
The biology of interferon actionsG Gastl, C Huber
European Journal of Immunology|November 1, 1982
Large granular lymphocytes: morphological studiesD Huhn, C Huber, G Gastl
Deutsche Medizinische Wochenschrift (1946)|September 30, 2004
[Complete remission of an idiopathic hypereosinophilic syndrome while using imatinib]D Wolf, G Gastl, H Rumpold
Oncology|January 1, 1985
Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trialC Huber, R Flener, G Gastl
Current Cancer Drug Targets|November 11, 2010
Current treatment concepts of Philadelphia-negative MPND Wolf, J Rudzki, G Gastl
Wiener Klinische Wochenschrift|January 6, 1984
[Löffler's parietal fibroplastic endocarditis--a case report]G Schnapka, G Gastl, F Hofstädter
Pageof 14